| Literature DB >> 32009414 |
Yu Li1, Zachary M Sandusky2, Rajender Vemula1, Qi Zhang1, Bulan Wu3, Shinji Fukuda2,4,5, Mingzong Li1, Deborah A Lannigan2,6,7, George A O'Doherty1.
Abstract
An asymmetric synthesis of two analogues of SL0101 (1) has been achieved. The effort is aimed at the discovery of inhibitors of the p90 ribosomal S6 kinase (RSK) with improved bioavailability. The route relies upon the use of the Taylor catalyst to regioselectively install C-3″ acetyl or carbamate functionality. This study led to the identification of a third-generation analogue of SL0101 with a C-4″ n-Pr-carbamate and a C-3″ acetate with improved RSK inhibitory activity.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32009414 PMCID: PMC7292201 DOI: 10.1021/acs.orglett.0c00042
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005